Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Heart

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/hrt.81.2.134PMID 9922347PMCID PMC1728923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monocytes.

  1998cited by this paper
• Increased monocyte tissue factor expression in coronary disease.

  1995cited by this paper
• PLATELET VON-WILLEBRAND-FACTOR AND BLEEDING IN CHRONIC-RENAL-FAILURE

  1995cited by this paper
• Marked Increase of Activated Factor VII in Uremic Patients

  1995cited by this paper
• Hemostasis in renal disease: pathophysiology and management.

  1994cited by this paper
• Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.

  1994cited by this paper
• Determination of plasma tissue factor antigen and its clinical significance

  1994cited by this paper
• Increased Tissue Factor Pathway Inhibitor Levels in Uremic Patients on Regular Hemodialysis

  1994cited by this paper
• Increased Expression of Neutrophil and Monocyte Adhesion Molecules in Unstable Coronary Artery Disease

  1993cited by this paper
• Disseminated intravascular coagulation in a patient with haemophilia B during factor IX replacement therapy

  1993cited by this paper
• The present status of tissue factor pathway inhibitor.

  1992cited by this paper
• The Expression of Surface Tissue Factor Apoprotein by Blood Monocytes in the Course of Infections in Early Infancy

  1992cited by this paper
• Factor VII hyperactivity in chronic dialysis patients.

  1992cited by this paper
• The role of leukocytes in the activation of blood coagulation.

  1992cited by this paper
• The role of leukocytes in the activation of blood coagulation.

  1992cited by this paper
• Initiation and regulation of tissue factor-dependent blood coagulation.

  1992cited by this paper
• Transient Intermittent Lymphocyte Activation Is Responsible for the Instabilit of Angina

  1992cited by this paper
• Changes in plasma levels of thrombomodulin during haemodialysis.

  1992cited by this paper
• Enhanced coagulation-fibrinolysis in patients on regular hemodialysis treatment.

  1991cited by this paper
• Human monocyte characteristics are altered in hypercholesterolaemia.

  1991cited by this paper
• Low Levels of the Anticoagulant Activity of Protein C in Patients with Chronic Renal Insufficiency: an Inhibitor of Protein C Is Present in Uremic Plasma

  1991cited by this paper
• Lipid abnormalities in chronic renal insufficiency.

  1991cited by this paper
• Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.

  1991cited by this paper
• Tuftsin induces tissue factor-like activity in human mononuclear cells and in monocytic cell lines.

  1990cited by this paper
• Flow cytometric analysis of tissue factor (TF) expression on stimulated monocytes — comparison to procoagulant activity of mononuclear blood cells

  1990cited by this paper
• Plasma thrombomodulin in health and diseases.

  1990cited by this paper
• Procoagulant activity expression by macrophages from atheromatous vascular plaques.

  1989cited by this paper
• Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

  1989cited by this paper
• Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL.

  1989cited by this paper
• Protein C assays in uremia.

  1989cited by this paper
• Tissue factor and hemostasis.

  1988cited by this paper
• The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action

  1988cited by this paper
• Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes.

  1988cited by this paper
• Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.

  1987cited by this paper
• ANTITHROMBIN III AND HEPARIN COFACTOR II IN PATIENTS WITH CHRONIC RENAL FAILURE

  1987cited by this paper
• Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits.

  1987cited by this paper
• A rapid, no-wash technic for immunophenotypic analysis by flow cytometry.

  1986cited by this paper
• Should hyperlipemia of renal failure be treated?

  1985cited by this paper
• Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death.

  1984cited by this paper
• Monocytic origin of foam cells in human atherosclerotic plaques.

  1984cited by this paper
• Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues.

  1983cited by this paper
• Increased Tissue Thromboplastin Activity in Monocytes of Patients with Meningococcal Infection: Related to an Unfavourable Prognosis

  1983cited by this paper
• Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis.

  1983cited by this paper
• Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias.

  1983cited by this paper
• Effect of immune complex-containing sera from patients with rheumatic diseases on thromboplastin activity of monocytes.

  1982cited by this paper
• Thrombosis in the pathogenesis of sudden cardiac death and myocardial infarction.

  1982cited by this paper
• Thrombosis in the pathogenesis of sudden cardiac death and myocardial infarction.

  1982cited by this paper
• A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.

  1981cited by this paper
• Factor VIII complex in uraemia and effects of haemodialysis.

  1981cited by this paper
• Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro.

  1981cited by this paper
• Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells.

  1981cited by this paper
• Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice

  1981cited by this paper
• The role of hypertension in hemodialysis-associated atherosclerosis.

  1980cited by this paper
• In vitro stimulation of tissue thromboplastin (factor III) activity in human monocytes by immune complexes and lectins.

  1979cited by this paper
• Arterial calcification and pathology in uremic patients undergoing dialysis.

  1979cited by this paper
• Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages.

  1979cited by this paper
• Tissue factor generation by human mononuclear cells: effects of endotoxin and dissociation of tissue factor generation from mitogenic response.

  1977cited by this paper
• Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes.

  1977cited by this paper
• The Endotoxin‐induced Coagulant Activity of Human Monocytes

  1975cited by this paper
• Accelerated atherosclerosis in prolonged maintenance hemodialysis.

  1974cited by this paper
• Coagulant activity of leukocytes. Tissue factor activity.

  1972cited by this paper
• CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography

  year unknowncited by this paper
• Coagulant Activity of Leukocytes TISSUE FACTOR ACTIVITY

  year unknowncited by this paper

• Myeloid cell-derived coagulation tissue factor is associated with renal tubular damage in mice fed an adenine diet

  2021cites this paper
• EFFECTS OF STEP TRAINING ON THE KIDNEYS FOLLOWING SPINAL CORD INJURY IN RATS By

  2017cites this paper
• Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients

  2017cites this paper
• Impact of blood urea nitrogen to creatinine ratio on mortality and morbidity in hemodialysis patients: The Q-Cohort Study

  2017cites this paper
• The effects inclusion of reducing low protein diet in patients with diabetes complicate type 1 and hypertension

  2016cites this paper
• Coagulation, thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis compared with healthy volunteers: a prospective analysis

  2016cites this paper
• Haemodiafiltration elicits less platelet activation compared to haemodialysis

  2016cites this paper
• Effects of taurine and housing density on renal function in laying hens

  2016cites this paper
• The vulnerable patient with chronic kidney disease.

  2016cites this paper
• Effects of step training on the kidneys following spinal cord injury in rats.

  2014cites this paper
• Short- and long-term effects of hemodialysis on platelet and monocyte activity markers of atherosclerosis in patients with end-stage renal disease.

  2013cites this paper
• Thrombin-Anti-Thrombin Levels and Patency of Arterio-Venous Fistula in Patients Undergoing Haemodialysis Compared to Healthy Volunteers: A Prospective Analysis

  2013cites this paper
• Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome.

  2012cites this paper
• Nutritional compounds influence tissue factor expression and inflammation of chronic kidney disease patients in vitro.

  2011cites this paper
• Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.

  2010cites this paper
• Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment

  2009cites this paper
• Impact of decreased renal function on coagulation and fibrinolysis in patients with non-valvular atrial fibrillation.

  2009cites this paper
• The association of serum lipids with renal function: the Korea Medical Institute Study

  2009cites this paper
• Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function.

  2008cites this paper
• The isoflavone genistein inhibits LPS-stimulated TNFalpha, but not IL-6 expression in monocytes from hemodialysis patients and healthy subjects.

  2006cites this paper
• The treatment of coronary artery disease in patients with chronic kidney disease.

  2006cites this paper
• The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.

  2006cites this paper
• Evaluation and treatment of ischemic cardiac risk

  2006cites this paper
• Independent, Non-traditional Risk Factors for Cardiovascular Events and Atherothrombosis in Chronic Kidney Disease and in Hemodialysis-dependent Patients

  2006cites this paper
• Anticoagulation in continuous renal replacement therapy

  2004cites this paper
• Cardiovascular disease and chronic kidney disease: insights and an update.

  2004cites this paper
• Lipids and atherosclerosis

  2004cites this paper
• Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model.

  2003cites this paper
• Tissue Factor, Its Pathway Inhibitor, and Metabolic Disturbances in Long-Term Peritoneal Dialysis

  2003cites this paper
• Protein kinase C (PKC) dependent induction of tissue factor (TF) by mesangial cells in response to inflammatory mediators and release during apoptosis

  2002cites this paper
• Tissue Factor and Thrombomodulin in Hemodialysis Patients: Associations with Endothelial Injury, Liver Disease, and Erythropoietin Therapy

  2002cites this paper
• Tissue factor – a therapeutic target for thrombotic disorders

  2002cites this paper
• Section VII. Vascular disease and risk factors.

  2002cites this paper
• Haemodialysis, atherosclerosis and inflammation-identifying molecular mechanisms of chronic vascular disease in ESDR patients.

  2002cites this paper
• Monocyte Activation in Peripheral Blood and Dialyser Eluates: Phenotypic Profile and Cytokine Release

  2002cites this paper
• Tissue Factor Expression on Monocyte Subpopulations during Normal Pregnancy

  2002cites this paper
• Medical and revascularization management in acute coronary syndrome in renal patients.

  2001cites this paper
• Anticoagulation in continuous renal replacement therapy.

  2001cites this paper
• Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia.

  2001cites this paper
• Vascular Endothelial Growth Factor KDR Receptor Signaling Potentiates Tumor Necrosis Factor-induced Tissue Factor Expression in Endothelial Cells*

  2001cites this paper
• Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients: relationship with systemic inflammation and haemostatic activation

  2001cites this paper
• Activated Polymorphonuclear Leukocytes and Monocytes in the Peripheral Blood of Patients with Ischemic Heart and Brain Conditions Correspond to the Presence of Multiple Risk Factors for Atherothrombosis

  2000cites this paper
• Cardiac complications of end-stage renal disease.

  2000cites this paper
• Hyperlipidaemia and cardiovascular disease

  year unknowncites this paper